Cloud Banner

Medical Devices

Image

North America Bioinformatics Market – Industry Trends and Forecast to 2029

  • Medical Devices
  • Published Report
  • Aug 2022
  • North America
  • 350 Pages
  • No of Tables: 140
  • No of Figures: 48

North America Bioinformatics Market, By Type (Knowledge Management Tools, Bioinformatics Software and Services), Sector (Medical Biotechnology, Academics, Animal Biotechnology, Agricultural Biotechnology, Environmental Biotechnology, Forensic Biotechnology and Others), Application (Genomics & Drug Development, Proteomics, Evolutionary Studies, Agricultural Studies, Veterinary Science, Metabolomics, Transcriptomics and Others), Purchase Mode (Group Purchase and Individual Purchase), Method (Genomics and Proteomics) End-User, (Research and Academic Institutes, Clinical Research Organization, Biotech and Pharmaceutical Companies, Research Laboratories, Hospital and Others) - Industry Trends and Forecast to 2029.

Bioinformatics Market

North America Bioinformatics Market Analysis and Insights

The drivers responsible for the growth of the  bioinformatics market are the less cost of genetic sequencing per base, growing need for bioinformatics, wide product portfolio offered by major market players and use of bioinformatics in personalized medicine and increased public-private sector funding for bioinformatics. However, factors expected to restrain the market growth are the rise in the cost of instrumentation, difficulty in clinical bioinformatics analysis and cyber security in bioinformatics.

Bioinformatics Market

Bioinformatics Market

On the other hand, strategic initiatives by market players, product development, advancements in bioinformatics technology and a rise in healthcare expenditure may act as an opportunity for the growth of the  bioinformatics market. However, the need for skilled expertise, challenges in implementing bioinformatics technology in clinical laboratories and regulatory approval may create challenges for the  bioinformatics market. There are recent developments related to the worldwide  bioinformatics market.

The rising demand for use of bioinformatics in drug development and design is expected to drive the market growth in North America. Data Bridge Market Research analyzes that the North America Bioinformatics market will grow at a CAGR of 21.8% during the forecast period of 2022 to 2029.

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2019 - 2014)

Quantitative Units

Revenue in USD Million, Pricing in USD

Segments Covered

By Type (Knowledge Management Tools, Bioinformatics Software and Services), Sector (Medical Biotechnology, Academics, Animal Biotechnology, Agricultural Biotechnology, Environmental Biotechnology, Forensic Biotechnology and Others), Application (Genomics & Drug Development, Proteomics, Evolutionary Studies, Agricultural Studies, Veterinary Science, Metabolomics, Transcriptomics and Others), Purchase Mode (Group Purchase and Individual Purchase), Method (Genomics and Proteomics) End-User, (Research and Academic Institutes, Clinical Research Organization, Biotech and Pharmaceutical Companies, Research Laboratories, Hospital and Others)

Countries Covered

The U.S., Canada, and Mexico

Market Players Covered

Thermo Fisher Scientific Inc., Illumina, Inc., Agilent Technologies, Inc., QIAGEN, SOPHiA GENETICS., BGI, Eurofins Scientific, Water Corporation, Partek Incorporated, DNASTAR, Dassault Systèmes, Bayer AG, DNANEXUS, INC., PerkinElmer Inc., Seven Bridges Genomics, Quest Diagnostics Incorporated., AstridBio Technologies Inc., BioBam, GenoFAB, Inc. Among others

Market Definition

Bioinformatics combines computer programming, big data, and Molecular Biology, which enables scientists to understand and identify patterns in biological data. It is particularly useful in studying genomes and DNA sequencing, as it allows scientists to organize large amounts of data.

From genetics to toxicology to mycology and radiobiology, there are scores of branches of Biology to specialize in. And out of the many, Bioinformatics is one of the intriguing fields which enables you to identify, evaluate, store, and retrieve biological information. Being an interdisciplinary field of study, it incorporates various applications of Computer Science, Statistics, and Biology to develop software applications for understanding biological data like DNA sequencing, protein analysis, evolutionary genetics, etc.

In the coming future, important decisions related to bioinformatics on drug discovery will be made by individuals who not only understand the biology but can also use the bioinformatics tools and the knowledge they release to develop hypotheses and identify quality targets

North America Bioinformatics Market Dynamics

Drivers

  • Decrease in The Cost of Genetic Sequencing Per Base

Oral health is one of the most important aspects of maintaining the health of gums, teeth and the oral-facial system, which allows for speaking, chewing and smiling. According to World Health Organization's report on March 25th, 2020, around 2.3 billion people worldwide are suffering from caries of a permanent tooth, among which around 530 million children suffer from caries of the primary tooth. In North America, periodontal disease has a high prevalence among all age groups. Thereby due to rising periodontal dental disorders, the availability and usage of intraoral scanners are anticipated to boost the market's growth.

  • Growing Need for Bioinformatics

As genomics-focused pharmacology continues to play a greater role in the treatment of various chronic diseases, especially cancer, next-generation sequencing (NGS) is evolving as a powerful tool for providing a deeper and more precise insight into the molecular underpinnings of individual tumors and specific receptors. Informatics is essential in biological research involving biologists who learn programming, computer programmers, mathematicians, or database managers who learn the foundations of biology.

Opportunities

  • Product Development in Recent Years

The growth curve for  bioinformatics market clinical applications is following an upward trend as established applications are gaining momentum and new ones are finding a foothold. Product development in the past years has helped the market size to grow. This also shows the support of the regulatory agency for allowing these products in the market.

For instance-

  • In June 2021, Agilent Technologies, Inc. released a new exome design called Sure Select Human All Exon V8 that offers specific content and current coverage of protein-coding areas from Refuses, CCDS and GENCODE. Additionally, it includes exons that are challenging to capture and the TERT promoter, which are neglected by competing exomes

The product development in recent years has shown the potential of these technologies and the companies working in this market are trying to get the more advanced product in the market, which is expected to create a lucrative opportunity for market growth in the forecast period.

  • Strategic Initiatives by Market Players

The demand for bioinformatics is increasing in the market owing to the increased levels of research and development along with the growth of the bioinformatics services market aided by the desire for innovative medications. Thus, the top market players have implemented a new strategy by developing new products and collaborating with other market players to improve business operations and profitability.

For instance-

  • In January 2020, Charles River underwent a strategic alliance with FiOS Genomics to acquire knowledge in bioinformatics, statistics and biology to help with the collection and analysis of high-dimensional, multi-variant datasets related to drug development, such as microarrays, next-generation sequencing (NGS), proteomics, metabolomics and epigenetics, as well as the related meta-data

These strategic initiatives by the market players, including acquisition, conferences and focused segment product launches, are helping them grow and improve the company's product portfolio, ultimately leading to more revenue generation. Hence, these strategic initiatives by the market players may be expected to as an opportunity that is expected to drive market growth.

Restraints/Challenges

  • Difficulty in Clinical Bioinformatics Analysis

The largely untapped potential of big data analytics is a feed buzz that has been exacerbated by the production of many next-generation data sets that seek to answer long-standing questions about the biology of human diseases. Although these approaches are likely to be a powerful means of unveiling new biological insights, several significant challenges currently hinder efforts to harness the power of big data. Typical challenges include the effective assessment of analytical software tools, the speeding up of the overall process using hybrid parallel computing (HPC) parallelization and acceleration technology, the advancement of automation strategies, data storage alternatives, and, finally, the development of new methods for the full utilization of results across multiple experimental conditions.

  • Challenges to Implementing Bioinformatics Technology in The Clinical Labs

Bioinformatics technologies can perform massively complicated biological data analysis. This capacity simultaneously facilitates the computational tools for the organization and analysis of biological data, which helps improve diagnostic screening. The application of these powerful technologies in a clinical laboratory poses a challenge because of the data's scope, quantity and medico-technical consequences.

Various challenges of implementing next-generation sequencing in the clinical laboratory are as follows-

  • One of the first areas where problems can creep in is often the most overlooked: "sample quality". Although platforms are often tested and compared using highly curated samples (such as the reference material from the Genome in a Bottle Consortium), real-world samples often present much more of a challenge and hence act as a challenge for the rise in demand
  • High turn-around time is also a major challenge for the instruments working in this market

COVID-19 Impact on the North America Bioinformatics Market

During the pandemic, the North Bioinformatics sector is one that focuses on using a combination of biology and information technology. At the heart of the industry is biological data, which is analyzed and transformed using IT techniques. Bioinformatics has always had huge potential in providing essential support to many areas of scientific research. The tools that Bioinformatics can provide allow scientists to get to grips with larger data sets and to mine and analyze them to discover crucial information that could lead to key discoveries. Genetics and genomes have been the primary focus of Bioinformatics in recent years, including comparative genomics, DNA microarrays, and functional genomics.

Recent Developments

  • In March 2022, Thermo Fisher Scientific Inc launched the CE-IVD Marked Next-Generation Sequencing (NGS) Instrument for Use in Clinical Labs. The CE-IVD Marked Next-Generation Sequencing Instrument is used to perform diagnostic testing and clinical research on a single instrument. The launch of the instrument resulted in the addition of a new product in the product range and the distribution of the NGS instrument, which is expected to increase the product revenue.

North America Bioinformatics Market Scope

North America bioinformatics market is segmented on the basis of six segments: type, sector, application, purchase mode, genomics, and end user. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

  • Knowledge Management Tools
  • Bioinformatics Software
  • Services

On the basis of type, the North America bioinformatics market is segmented into knowledge management tools, bioinformatics software, and services.

Sector

  • Medical biotechnology
  • Academics
  • Animal Biotechnology
  • Agricultural biotechnology
  • Environmental Biotechnology
  • Forensic biotechnology
  • Others

On the basis of sector, the North America bioinformatics market is segmented into medical biotechnology, academics, animal biotechnology, agricultural biotechnology, environmental biotechnology, forensic biotechnology, and others.

Application

  • Genomics and Drug Development
  • Proteomics
  • Evolutionary Studies
  • Agricultural Studies
  • Veterinary Science
  • Metabolomics
  • Transcriptomics
  • Others

On the basis of application, the North America bioinformatics market is segmented into genomics and drug development, proteomics, evolutionary studies, agricultural studies, veterinary science, metabolomics, transcriptomics, and others.

Purchase Mode

  • Group Purchase
  • Individual Purchase

On the basis of purchase mode, the North America bioinformatics market is segmented into group purchases and individual purchases.

Method

  • Genomics
  • Proteomics

On the basis of method, the North America bioinformatics market is segmented into genomics and proteomics.

End User

  • Research and Academic Institutes
  • Clinical Research Organization
  • Biotech and Pharmaceutical Companies
  • Research Laboratories
  • Hospital
  • Others

Bioinformatics Market

On the basis of end-user, the North America Bioinformatics market is segmented into research and academic institutes, clinical research organizations, biotech and pharmaceutical companies, research laboratories, hospitals, and others.

Pipeline Analysis

North America Bioinformatics Market Regional Analysis/Insights

North America bioinformatics market is analyzed, and market size insights and trends are provided by regions, type, sector, application, purchase mode, genomics, and end-user. as referenced above.

The countries covered in the North America bioinformatics market report are the U.S., Canada, and New Mexico. The U.S. is expected to dominate the market due to a rise in the incidence of periodontal diseases, a rise in medical tourism, a growth of technological innovations in bioinformatics, and a rise in research and development activity.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of  brands and their challenges faced due to large or scarce competition from local and domestic brands impact on sales channels are considered while providing forecast analysis of the country data.

Competitive Landscape and North America Bioinformatics Market Share Analysis

North America bioinformatics market competitive landscape provides details on the competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, the North America presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width, and breadth, and application dominance. The above data points provided are only related to the companies' focus related to the North America Bioinformatics market.

Some of the major players operating in the North America Bioinformatics market are Thermo Fisher Scientific Inc., Illumina, Inc., Agilent Technologies, Inc., QIAGEN, SOPHiA GENETICS., BGI, Eurofins Scientific, Water Corporation, Partek Incorporated, DNASTAR, Dassault Systèmes, Bayer AG, DNANEXUS, INC., PerkinElmer Inc., Seven Bridges Genomics, Quest Diagnostics Incorporated., AstridBio Technologies Inc., BioBam, GenoFAB, Inc. among others.


SKU-

TABLE 1 BIOINFORMATICSCOST PER SAMPLE

TABLE 2 NORTH AMERICA BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 3 NORTH AMERICA SERVICES IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 4 NORTH AMERICA SERVICES IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 5 NORTH AMERICA DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 6 NORTH AMERICA BIOINFORMATICS SOFTWARE IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 7 NORTH AMERICA BIOINFORMATICS SOFTWARE IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 8 NORTH AMERICA SEQUENCING DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 9 NORTH AMERICA SPECIALIZED BIOINFORMATICS APPLICATIONS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 10 NORTH AMERICA KNOWLEDGE MANAGEMENT TOOLS IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 11 NORTH AMERICA KNOWLEDGE MANAGEMENT TOOLS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 12 NORTH AMERICA BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)

TABLE 13 NORTH AMERICA MEDICAL BIOTECHNOLOGY IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 14 NORTH AMERICA ACADEMICS IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 15 NORTH AMERICA ANIMAL TECHNOLOGY IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 16 NORTH AMERICA AGRICULTURAL BIOTECHNOLOGY IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 17 NORTH AMERICA ENVIRONMENTAL BIOTECHNOLOGY IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 18 NORTH AMERICA FORENSIC BIOTECHNOLOGY IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 19 NORTH AMERICA OTHERS IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 20 NORTH AMERICA BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 21 NORTH AMERICA GENOMICS & DRUG DEVELOPMENT IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 22 NORTH AMERICA GENOMICS & DRUG DEVELOPMENT IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 23 NORTH AMERICA GENOMICS & DRUG DEVELOPMENT BY TYPE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 24 NORTH AMERICA PROTEOMICS IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 25 NORTH AMERICA PROTEOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 26 NORTH AMERICA AGRICULTURAL STUDIES IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 27 NORTH AMERICA AGRICULTURAL STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 28 NORTH AMERICA TRANSCRIPTOMICS IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 29 NORTH AMERICA TRANSCRIPTOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 30 NORTH AMERICA METABOLOMICS IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 31 NORTH AMERICA METABOLOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 32 NORTH AMERICA EVOLUTIONARY STUDIES IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 33 NORTH AMERICA EVOLUTIONARY STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 34 NORTH AMERICA VETERINARY SCIENCE IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 35 NORTH AMERICA VETERINARY SCIENCE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 36 NORTH AMERICA OTHERS IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 37 NORTH AMERICA OTHERS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 38 NORTH AMERICA BIOINFORMATICS MARKET, BY PURCHASE MODE, 2020-2029 (USD MILLION)

TABLE 39 NORTH AMERICA GROUP PURCHASE IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 40 NORTH AMERICA INDIVIDUAL PURCHASE IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 41 NORTH AMERICA BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 42 NORTH AMERICA GENOMICS IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 43 NORTH AMERICA GENOMICS IN BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 44 NORTH AMERICA PROTEOMICS IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 45 NORTH AMERICA BIOINFORMATICS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 46 NORTH AMERICA RESEARCH AND ACADEMIC INSTITUTES IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 47 NORTH AMERICA CLINICAL RESEARCH ORGANIZATION IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 48 NORTH AMERICA BIOTECH AND PHARMACEUTICAL COMPANIES IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 49 NORTH AMERICA RESEARCH LABORATORIES IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 50 NORTH AMERICA HOSPITALS IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 51 NORTH AMERICA OTHERS IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 52 NORTH AMERICA BIOINFORMATICS MARKET, BY COUNTRY, 2020-2029 (USD MILLION)

TABLE 53 NORTH AMERICA BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 54 NORTH AMERICA SERVICES IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 55 NORTH AMERICA DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 56 NORTH AMERICA BIOINFORMATICS SOFTWARE IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 57 NORTH AMERICA SEQUENCING DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 58 NORTH AMERICA SPECIALIZED BIOINFORMATICS APPLICATIONS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 59 NORTH AMERICA KNOWLEDGE MANAGEMENT TOOLS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 60 NORTH AMERICA BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)

TABLE 61 NORTH AMERICA BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 62 NORTH AMERICA GENOMICS & DRUG DEVELOPMENT IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 63 NORTH AMERICA GENOMICS & DRUG DEVELOPMENT BY TYPE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 64 NORTH AMERICA PROTEOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 65 NORTH AMERICA AGRICULTURAL STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 66 NORTH AMERICA AGRICULTURAL STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 67 NORTH AMERICA METABOLOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 68 NORTH AMERICA EVOLUTIONARY STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 69 NORTH AMERICA VETERINARY SCIENCE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 70 NORTH AMERICA OTHERS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 71 NORTH AMERICA BIOINFORMATICS MARKET, BY PURCHASE MODE, 2020-2029 (USD MILLION)

TABLE 72 NORTH AMERICA BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 73 NORTH AMERICA GENOMICS IN BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 74 NORTH AMERICA. BIOINFORMATICS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 75 U.S. BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 76 U.S. SERVICES IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 77 U.S. DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 78 U.S. BIOINFORMATICS SOFTWARE IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 79 U.S. SEQUENCING DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 80 U.S. SPECIALIZED BIOINFORMATICS APPLICATIONS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 81 U.S. KNOWLEDGE MANAGEMENT TOOLS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 82 U.S. BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)

TABLE 83 U.S. BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 84 U.S. GENOMICS & DRUG DEVELOPMENT IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 85 U.S. GENOMICS & DRUG DEVELOPMENT BY TYPE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 86 U.S. PROTEOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 87 U.S. AGRICULTURAL STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 88 U.S. TRANSCRIPTOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 89 U.S. METABOLOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 90 U.S. EVOLUTIONARY STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 91 U.S. VETERINARY SCIENCE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 92 U.S. OTHERS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 93 U.S. BIOINFORMATICS MARKET, BY PURCHASE MODE, 2020-2029 (USD MILLION)

TABLE 94 U.S. BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 95 U.S GENOMICS IN BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 96 U.S. BIOINFORMATICS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 97 CANADA BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 98 CANADA SERVICES IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 99 CANADA DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 100 CANADA BIOINFORMATICS SOFTWARE IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 101 CANADA SEQUENCING DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 102 CANADA SPECIALIZED BIOINFORMATICS APPLICATIONS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 103 CANADA KNOWLEDGE MANAGEMENT TOOLS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 104 CANADA BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)

TABLE 105 CANADA BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 106 CANADA GENOMICS & DRUG DEVELOPMENT IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 107 CANADA GENOMICS & DRUG DEVELOPMENT BY TYPE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 108 CANADA PROTEOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 109 CANADA AGRICULTURAL STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 110 CANADA TRANSCRIPTOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 111 CANADA METABOLOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 112 CANADA EVOLUTIONARY STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 113 CANADA VETERINARY SCIENCE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 114 CANADA OTHERS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 115 CANADA BIOINFORMATICS MARKET, BY PURCHASE MODE, 2020-2029 (USD MILLION)

TABLE 116 CANADA BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 117 CANADA GENOMICS IN BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 118 CANADA BIOINFORMATICS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 119 MEXICO BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 120 MEXICO SERVICES IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 121 MEXICO DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 122 MEXICO BIOINFORMATICS SOFTWARE IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 123 MEXICO SEQUENCING DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 124 MEXICO SPECIALIZED BIOINFORMATICS APPLICATIONS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 125 MEXICO KNOWLEDGE MANAGEMENT TOOLS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 126 MEXICO BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)

TABLE 127 MEXICO BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 128 MEXICO GENOMICS & DRUG DEVELOPMENT IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 129 MEXICO GENOMICS & DRUG DEVELOPMENT BY TYPE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 130 MEXICO PROTEOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 131 MEXICO AGRICULTURAL STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 132 MEXICO TRANSCRIPTOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 133 MEXICO METABOLOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 134 MEXICO EVOLUTIONARY STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 135 MEXICO VETERINARY SCIENCE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 136 MEXICO OTHERS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 137 MEXICO BIOINFORMATICS MARKET, BY PURCHASE MODE, 2020-2029 (USD MILLION)

TABLE 138 MEXICO BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 139 MEXICO GENOMICS IN BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 140 MEXICO BIOINFORMATICS MARKET, BY END USER, 2020-2029 (USD MILLION)

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The North America Bioinformatics Market will grow at a CAGR of 21.8% by 2029.
The significant factors flourishing the growth of the North America Bioinformatics Market are Decrease in The Cost of Genetic Sequencing Per Base, and Growing Need for Bioinformatics.
The major players operating in the North America Bioinformatics Market are Thermo Fisher Scientific Inc., Illumina, Inc., Agilent Technologies, Inc., QIAGEN, SOPHiA GENETICS., BGI, Eurofins Scientific, Water Corporation, Partek Incorporated, DNASTAR, Dassault Systèmes, Bayer AG, DNANEXUS, INC., PerkinElmer Inc., Seven Bridges Genomics, Quest Diagnostics Incorporated., AstridBio Technologies Inc., BioBam, GenoFAB, Inc. Among others.
The major countries covered in the North America Bioinformatics Market are The U.S., Canada, and Mexico.
Free Sample Report

CHOOSE LICENCE TYPE

  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials